University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Lee Silverman Voice Treatment versus NHS Speech and Language Therapy versus control for dysarthria in Parkinson’s disease (PD COMM) : a UK, multicentre, pragmatic, randomised controlled trial.

Simple item page
dc.contributor.authorRick, Caroline
dc.contributor.authorSackley, Catherine
dc.contributor.authorBrady, M
dc.contributor.authorWoolley , R.L.
dc.contributor.authorBurton, Chris
dc.contributor.authorPatel, S.
dc.contributor.authorMasterson-Algar, Patricia
dc.contributor.authorNicoll, Avril
dc.contributor.authorChristina, Smith
dc.contributor.authorJowett, Sue
dc.contributor.authorIves, N. J.
dc.contributor.authorBeaton, Gillian
dc.contributor.authorDickson, Sylvia
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Women’s Health Researchen
dc.date.accessioned2024-11-11T14:07:01Z
dc.date.available2024-11-11T14:07:01Z
dc.date.issued2024-07-10
dc.descriptionAcknowledgments This study is funded by the National Institute for Health Research, Health Technology Assessment programme (HTA: 10/135/02). The views expressed are those of the authors and not necessarily those of the National Institute for Health and Care Research or the Department of Health and Social Care. We thank the members of the PD COMM DMC (Carl Counsell (chair), consultant neurologist, University of Aberdeen; Katherine Deane, Senior lecturer, University of East Anglia; and Louise Hiller, statistician, University of Warwick) and the trial steering committee (Catherine M Sackley (chief investigator), Carl E Clarke (deputy chief investigator), Pui Au, Naveed Saeed, Jane Futterer, Gillian Beaton, Marian Brady, Sue Jowett, Smitaa Patel, and Natalie Ives) for their time and support of the trial. The study authors also wish to thank Pauline Campbell for her work on reviewing the background evidence on SLT interventions for this project. We thank The Dunhill Medical Trust for funding the pilot trial, Parkinson’s UK, South Birmingham; Chris Jeffery for membership of the trial steering committee; Leslie Sharp for input to the delivery and reporting; and Tony Jefferys who reviewed the paper as a patient representative.en
dc.description.statusPeer revieweden
dc.format.extent12
dc.format.extent351284
dc.identifier289476622
dc.identifierdcad930e-5b06-4d7e-8123-0941295ed689
dc.identifier85198417974
dc.identifier.citationRick, C, Sackley, C, Brady, M, Woolley , R L, Burton, C, Patel, S, Masterson-Algar, P, Nicoll, A, Christina, S, Jowett, S, Ives, N J, Beaton, G & Dickson, S 2024, 'Lee Silverman Voice Treatment versus NHS Speech and Language Therapy versus control for dysarthria in Parkinson’s disease (PD COMM) : a UK, multicentre, pragmatic, randomised controlled trial.', BMJ, vol. 386, e078341. https://doi.org/10.1136/bmj-2023-078341en
dc.identifier.doi10.1136/bmj-2023-078341
dc.identifier.issn0959-8146
dc.identifier.otherORCID: /0000-0001-9677-4817/work/171447951
dc.identifier.urihttps://hdl.handle.net/2164/24600
dc.identifier.vol386en
dc.language.isoeng
dc.relation.ispartofBMJen
dc.subjectR Medicineen
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.titleLee Silverman Voice Treatment versus NHS Speech and Language Therapy versus control for dysarthria in Parkinson’s disease (PD COMM) : a UK, multicentre, pragmatic, randomised controlled trial.en
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Sackley_etal_BMJ_Lee_Silverman_Voice_VoR.pdf
Size:
343.05 KB
Format:
Adobe Portable Document Format
Download

Collections

All research